Content of matrix metalloproteinases in the blood of hypertensive patients with a high cardiovascular risk receiving statin therapy

Aim. To compare the effect of atorvastatin and rosuvastatin as part of complex therapy in patients with hypertension (HTN) with a high cardiovascular risk on the level of matrix metalloproteinases -1, -9 (MMP-1, MMP-9) and tissue inhibitors of metalloproteinases -1, -4 (TIMP-1, TIMP-4).Material and...

詳細記述

書誌詳細

出版年:	Кардиоваскулярная терапия и профилактика
主要な著者:	V. P. Mikhin, O. A. Osipova, V. V. Vorotyntseva, D. N. Perutsky, N. I. Golovina
フォーマット:	論文
言語:	ロシア語
出版事項:	«SILICEA-POLIGRAF» LLC 2022-11-01
主題:	hypertension cardiovascular risk statins matrix metalloproteinases tissue inhibitors of metalloproteinases
オンライン･アクセス:	https://cardiovascular.elpub.ru/jour/article/view/3422